Eva Natukunda - Concepedia

Author

Eva Natukunda

Also Known As

Agnes Natukunda, D Muganzi, Eva Natukunda, Evalyn Natukunda, Lufina Tsirizani Galileya, Margret Nansumba, Victor Musiime

Publications

230

Citations

H-Index

Concepts

All Affiliations

Joint Clinical Research Centre Gilead Sciences (United States)Khon Kaen University St. Jude Children's Research Hospital University of Zimbabwe

About

Eva Natukunda is an author at Joint Clinical Research Centre specializing in pharmacotherapy, hiv, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	49
2	Hiv	2	2	49
3	Pharmacology	1	1	29
4	Hiv/aids Counselling	1	1	29
5	Pediatrics	1	1	20

Eva Natukunda

Publications

168

Citations

H-Index

Page 1

	Year	Citations
Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy Andrew J. Prendergast, Mutsa Bwakura‐Dangarembizi, Adrian Cook, AIDS	2011	48
Pediatric Underdosing of Efavirenz Quirine Fillekes, Eva Natukunda, J Balungi, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	37
Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial Eva Natukunda, Aditya H. Gaur, Pope Kosalaraksa, The Lancet Child & Adolescent Health Hiv/aids CounsellingTreatment And PreventionMedicineAntiviral Drug DevelopmentAntiviral Therapy	2017	29
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial Aditya H. Gaur, Mark F. Cotton, Carina A. Rodriguez, The Lancet Child & Adolescent Health Fixed-dose Combination BictegravirTreatment And PreventionWeek 48Antiviral Drug DevelopmentPediatrics	2021	20
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa Victor Musiime, Mutsa Bwakura‐Dangarembizi, Alexander J. Szubert, New England Journal of Medicine	2025	12
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials Chloe Orkin, Faïza Ajana, Cissy Kityo, JAIDS Journal of Acquired Immune Deficiency Syndromes	2021	11
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study Carina A. Rodriguez, Eva Natukunda, Renate Strehlau, The Lancet HIV	2024	11

Page 1